Growth Metrics

Moderna (MRNA) Change in Acquisitions & Divestments (2018 - 2025)

Moderna (MRNA) has disclosed Change in Acquisitions & Divestments for 8 consecutive years, with $3.8 billion as the latest value for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments rose 660.79% to $3.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.6 billion through Dec 2025, up 40.23% year-over-year, with the annual reading at $5.6 billion for FY2025, 40.23% up from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $3.8 billion at Moderna, up from $685.0 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $3.8 billion in Q4 2025, with the low at -$874.0 million in Q2 2025.
  • Average Change in Acquisitions & Divestments over 5 years is $1.1 billion, with a median of $965.5 million recorded in 2023.
  • The sharpest move saw Change in Acquisitions & Divestments skyrocketed 3234.38% in 2023, then plummeted 222.41% in 2025.
  • Over 5 years, Change in Acquisitions & Divestments stood at $2.0 billion in 2021, then tumbled by 34.68% to $1.3 billion in 2022, then tumbled by 34.84% to $864.0 million in 2023, then crashed by 178.82% to -$681.0 million in 2024, then soared by 660.79% to $3.8 billion in 2025.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $3.8 billion, $685.0 million, and -$874.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.